Diagnosis and treatment of non-gonococcal urethritis caused by atypical (intracellular) pathogens. What should a urologist know? Review of current clinical guidelines

Мұқаба

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

This review is devoted to specific features of diagnosis and treatment of non-gonococcal urethritis caused by intracellular microorganisms.

Using modern literature data and the up-to-date clinical guidelines, an analysis of changes in the epidemiological structure and resistance of intracellular pathogens in non-gonococcal urethritis has been carried out.

The current principles of diagnosis and treatment of non-gonococcal urethritis are reviewed, with a discussion of the place of new molecular genetic methods for detecting the resistance of some intracellular pathogens (Mycoplasma genitalium) in routine clinical practice.

Treatment regimens proposed by various clinical guidelines are compared and critically appraised in the review. Both clinical data and the results of in vitro studies on the efficiency of various drugs against certain intracellular pathogens of urethritis are presented.

Толық мәтін

Рұқсат жабық

Авторлар туралы

K. Lokshin

LLC "GMC Clinic"

Хат алмасуға жауапты Автор.
Email: k_lokshin@hotmail.com

Ph.D., MD, Head of the Center for Operative Urology, Oncourology and Andrology

Ресей, Moscow

Әдебиет тізімі

  1. Lokshin K.L. Review of current clinical recommendations for the diagnosis and treatment of urethritis. Urology today. 2020;4:1–2. Russain (Локшин К.Л. Обзор актуальных клинических рекомендаций по диагностике и лечению уретритов. Урология сегодня. 2020;4:1–2).
  2. Sexually Transmitted Infections Treatment Guidelines, Centers for Disease Control and prevention, Morbidity and Mortality Weekly Report, Recommendations and Reports / Vol. 70 / No. 4 July 23, 2021. https://www.cdc.gov/std/treatment-guidelines/STI-Guidelines-2021.pdf
  3. European Association of Urology Guidelines on Urological Infections, 2023 Edition. https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Urological-infections-2023.pdf
  4. Jensen J.S., Cusini M., Gomberg M., Moi H., Wilson J., Unemo M. 2021 European guideline on the management of Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2022;36(5):641–650. doi: 10.1111/jdv.17972. Epub 2022 Feb 19. PMID: 35182080.
  5. Horner P.J., Blee K., Falk L., van der Meijden W., Moi H. 2016 European guideline on the management of non-gonococcal urethritis. Int J STD AIDS. 2016;27(11):928–937. doi: 10.1177/0956462416648585. Epub 2016 May 4. PMID: 27147267.
  6. Chlamydia infection. Clinical recommendations of the Ministry of Health of the Russian Federation, 2021 https://cr.minzdrav.gov.ru/schema/194_1. Russian (Хламидийная инфекция. Клинические рекомендации МЗ РФ, 2021 г. https://cr.minzdrav.gov.ru/schema/194_1).
  7. Urogenital diseases caused by Mycoplasma genitalium. Clinical recommendations of the Ministry of Health of the Russian Federation, 2021. https://cr.minzdrav.gov.ru/schema/216_1. Russian (Урогенитальные заболевания, вызванные Mycoplasma genitalium. Клинические рекомендации МЗ РФ, 2021. https://cr.minzdrav.gov.ru/schema/216_1).
  8. Bachmann L.H., Kirkcaldy R.D., Geisler W.M., et al. Prevalence of Mycoplasma genitalium infection, antimicrobial resistance mutations and symptom resolution following treatment of urethritis [published online ahead of print, 2020 Mar 18]. Clin Infect Dis. 2020;ciaa293. doi: 10.1093/cid/ciaa293.
  9. Bissessor M., Tabrizi S.N., Twin J., et al. Macrolide resistance and azithromycin failure in a Mycoplasma genitalium-infected cohort and response of azithromycin failures to alternative antibiotic regimens. Clin Infect Dis. 2015;60(8):1228–1236. doi: 10.1093/cid/ciu1162
  10. Paez-Canro C., et al. Antibiotics for treating urogenital Chlamydia trachomatis infection in men and nonpregnant women. Cochrane Database Syst Rev, 2019. 2019: CD010871. https://pubmed.ncbi.nlm.nih.gov/30682211
  11. Bebear C.M. et al. Activity of moxifloxacin against the urogenital mycoplasma Ureaplasma spp., Mycoplasma hominis and Mycoplasma genitalium and Chlamydia trachomatis. Clin Microbiol Infect 2008;14:801–805.
  12. Takahashi S., Hamasuna R., Yasuda M., Ishikawa K., Hayami H., Uehara S., Yamamoto S., Minamitani S., Kadota J., Iwata S., Kaku M., Watanabe A., Sato J., Hanaki H., Masumori N., Kiyota H., Egawa S., Tanaka K., Arakawa S., Fujisawa M., Kumon H., Wada K., Kobayashi K., Matsubara A., Matsumoto T., Eto M., Tatsugami K., Kuroiwa K., Ito K., Hosobe T., Hirayama H., Narita H., Yamaguchi T., Ito S., Sumii T., Kawai S., Kanokogi M., Kawano H., Chokyu H., Uno S., Monden K., Kaji S., Kawahara M., Takayama K., Ito M., Yoshioka M., Kano M., Konishi T., Kadena H., Nishi S., Nishimura H., Yamauchi T., Maeda S., Horie M., Ihara H., Matsumura M., Shirane T., Takeyama K., Akiyama K., Takahashi K., Ikuyama T., Inatomi H., Yoh M. Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan. J Infect Chemother. 2016;22(9):581–86. doi: 10.1016/j.jiac.2016.06.010. Epub 2016 Jul 21. PMID: 27452428.
  13. Waites K.B., Duffy L.B., Schmid T., Crabb D., Pate M.S., Cassell G.H. In vitro susceptibilities of Mycoplasma pneu-moniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391. Antimicrob Agents Chemother. 1991;35(6):1181–1185. doi: 10.1128/AAC.35.6.1181. PMID: 1929260; PMCID: PMC284307.
  14. Jensen J.S., Bradshaw C. Management of Mycoplasma genitalium infections - can we hit a moving target? BMC Infect Dis. 2015;15:343. doi: 10.1186/s12879-015-1041-6. PMID: 26286546; PMCID: PMC4545773.
  15. Zarucheynova O.V. Development of a complex of diagnostic kits for the detection, identification and determination of antibiotic sensitivity of urogenital mycoplasmas. Abstract of the dissertation for the degree of Candidate of Biological Sciences. 2015, p. 1–25. Russian (Заручейнова О.В. Разработка комплекса диагностических наборов для выявления, идентификации и определения чувствительности к антибиотикам урогенитальных микоплазм. Автореферат диссертации на соискание ученой степени кандидата биологических наук. 2015 г. С. 1–25).
  16. Burkhardt O., Welte T. 10 years’ experience with the pneumococcal quinolone moxifloxacin. Expert Rev Anti Infect Ther. 2009;7(6):645–68.
  17. Schwebke J.R., Rompalo A., Taylor S., Seña A.C., Martin D.H., Lopez L.M., Lensing S., Lee J.Y. Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial. Clin Infect Dis. 2011;52(2):163–170. doi: 10.1093/cid/ciq074. PMID: 21288838; PMCID: PMC3106252.
  18. Manhart L.E., Gillespie C.W., Lowens M.S., Khosropour C.M., Colombara D.V., Golden M.R., Hakhu N.R., Thomas K.K., Hughes J.P., Jensen NL, Totten P.A. Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial. Clin Infect Dis. 2013;56(7):934–942. doi: 10.1093/cid/cis1022. Epub 2012 Dec 7. PMID: 23223595; PMCID: PMC3588116.
  19. Jernberg E., Moghaddam A., Moi H. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. International Journal of STD & AIDS 2008;19:676–679. doi: 10.1258/ijsa.2008.00803.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу
2. Figure. The ratio of moxifloxacin concentration in the tissues of the urogenital tract and MIIK "on some intracellular pathogens [11]

Жүктеу (60KB)
Метадеректер

© Bionika Media, 2024

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>